Macquarie Group LTD West Pharmaceutical Services Inc Transaction History

Macquarie Group LTD

  • $87.4 Billion
  • Q1 2024

A detailed history of Macquarie Group LTD transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Macquarie Group LTD holds 393,351 shares of WST stock, worth $127 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
393,351
Previous 572,871 31.34%
Holding current value
$127 Million
Previous $202 Million 22.84%
% of portfolio
0.18%
Previous 0.24%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$338.27 - $413.0 $60.7 Million - $74.1 Million
-179,520 Reduced 31.34%
393,351 $156 Million
Q4 2023

Feb 14, 2024
SELL
$318.29 - $392.21 $2.52 Million - $3.1 Million
-7,910 Reduced 1.36%
572,871 $202 Million
Q3 2023

Nov 14, 2023
SELL
$354.9 - $412.41 $905,349 - $1.05 Million
-2,551 Reduced 0.44%
580,781 $218 Million
Q2 2023

Aug 14, 2023
BUY
$334.63 - $382.47 $2.45 Million - $2.8 Million
7,322 Added 1.27%
583,332 $223 Million
Q1 2023

May 15, 2023
BUY
$232.5 - $346.47 $20.4 Million - $30.5 Million
87,948 Added 18.02%
576,010 $200 Million
Q4 2022

Feb 21, 2023
BUY
$209.34 - $261.61 $77.6 Million - $96.9 Million
370,589 Added 315.47%
488,062 $115 Million
Q3 2022

Nov 14, 2022
BUY
$246.08 - $343.65 $16.9 Million - $23.5 Million
68,476 Added 139.76%
117,473 $28.9 Million
Q2 2022

Aug 15, 2022
SELL
$280.61 - $420.45 $4.61 Million - $6.91 Million
-16,440 Reduced 25.12%
48,997 $14.8 Million
Q1 2022

May 16, 2022
SELL
$357.49 - $445.92 $1.11 Million - $1.39 Million
-3,113 Reduced 4.54%
65,437 $26.9 Million
Q4 2021

Feb 11, 2022
BUY
$402.25 - $471.34 $2.92 Million - $3.42 Million
7,247 Added 11.82%
68,550 $32.2 Million
Q3 2021

Nov 12, 2021
SELL
$363.01 - $468.47 $2.78 Million - $3.59 Million
-7,654 Reduced 11.1%
61,303 $26 Million
Q2 2021

Aug 13, 2021
SELL
$284.77 - $363.2 $224,683 - $286,564
-789 Reduced 1.13%
68,957 $24.8 Million
Q1 2021

May 14, 2021
BUY
$257.29 - $307.53 $16.1 Million - $19.2 Million
62,408 Added 850.48%
69,746 $19.7 Million
Q4 2020

Feb 16, 2021
BUY
$261.16 - $301.66 $177,327 - $204,827
679 Added 10.2%
7,338 $2.08 Million
Q3 2020

Nov 13, 2020
SELL
$224.99 - $288.02 $4.22 Million - $5.4 Million
-18,766 Reduced 73.81%
6,659 $1.83 Million
Q2 2020

Aug 11, 2020
SELL
$149.8 - $227.17 $2.96 Million - $4.48 Million
-19,733 Reduced 43.7%
25,425 $5.78 Million
Q1 2020

May 15, 2020
SELL
$128.96 - $174.76 $1.5 Million - $2.03 Million
-11,605 Reduced 20.44%
45,158 $6.88 Million
Q4 2019

Feb 14, 2020
BUY
$137.6 - $151.21 $521,641 - $573,237
3,791 Added 7.16%
56,763 $8.53 Million
Q3 2019

Nov 14, 2019
SELL
$121.41 - $150.02 $150,912 - $186,474
-1,243 Reduced 2.29%
52,972 $7.51 Million
Q2 2019

Aug 14, 2019
BUY
$111.27 - $125.15 $67,095 - $75,465
603 Added 1.12%
54,215 $6.79 Million
Q1 2019

May 15, 2019
SELL
$94.53 - $110.2 $5.36 Million - $6.25 Million
-56,678 Reduced 51.39%
53,612 $5.91 Million
Q4 2018

Feb 15, 2019
BUY
$93.0 - $123.98 $290,532 - $387,313
3,124 Added 2.92%
110,290 $10.8 Million
Q3 2018

Nov 15, 2018
SELL
$98.01 - $123.47 $4,606 - $5,803
-47 Reduced 0.04%
107,166 $13.2 Million
Q2 2018

Aug 14, 2018
BUY
$83.32 - $101.88 $65,489 - $80,077
786 Added 0.74%
107,213 $10.6 Million
Q1 2018

May 11, 2018
BUY
$85.56 - $102.4 $285,684 - $341,913
3,339 Added 3.24%
106,427 $9.4 Million
Q4 2017

Feb 15, 2018
SELL
$91.65 - $101.65 $1.1 Million - $1.21 Million
-11,952 Reduced 10.39%
103,088 $10.2 Million
Q3 2017

Nov 08, 2017
BUY
$84.54 - $96.75 $9.73 Million - $11.1 Million
115,040
115,040 $11.1 Million

Others Institutions Holding WST

# of Institutions
825
Shares Held
64.4M
Call Options Held
184K
Put Options Held
312K
View Full List

About WEST PHARMACEUTICAL SERVICES INC

WST Quotes by TradingView
  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email